What Researchers Did
The authors wrote a plan, called a protocol, for a future systematic review and meta-analysis of studies on hyperbaric oxygen therapy (HBOT) in people with ulcerative colitis.
What They Found
This protocol paper reports no results, because the review had not yet been carried out. It says the authors will search 12 databases, including Embase, MEDLINE, PubMed, Cochrane and several Chinese databases, from their start to November 2020. Two authors will work independently on picking articles, collecting data and judging study quality. The main outcome will be clinical effectiveness, and four secondary outcomes are planned. Data will be analyzed with RevMan 5.3 software. The abstract states that evidence on the efficacy and safety of HBOT for ulcerative colitis is inconclusive.
What This Means for Canadian Patients
The abstract gives no findings on whether HBOT helps people with ulcerative colitis or how safe it is. It describes only how a later review will look for and combine existing studies. Patients with ulcerative colitis should talk with their own doctor about any treatment choices, since this paper does not answer that question.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a protocol, this paper has no results to judge, and the quality of the final review will depend on the studies the authors find and on how well they carry out the plan.